Julien Lancelot

1.2k total citations
22 papers, 828 citations indexed

About

Julien Lancelot is a scholar working on Parasitology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Julien Lancelot has authored 22 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Parasitology, 17 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Julien Lancelot's work include Parasites and Host Interactions (18 papers), Histone Deacetylase Inhibitors Research (14 papers) and Macrophage Migration Inhibitory Factor (3 papers). Julien Lancelot is often cited by papers focused on Parasites and Host Interactions (18 papers), Histone Deacetylase Inhibitors Research (14 papers) and Macrophage Migration Inhibitory Factor (3 papers). Julien Lancelot collaborates with scholars based in France, Germany and Brazil. Julien Lancelot's co-authors include Raymond J. Pierce, Manfred Jung, Christophe Romier, Wolfgang Sippl, Martin Marek, Stéphanie Caby, Mathieu Vanderstraete, Jelena Melesina, Guilherme Oliveira and Alokta Chakrabarti and has published in prestigious journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Julien Lancelot

22 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julien Lancelot France 16 497 382 173 149 111 22 828
Jelena Melesina Germany 16 715 1.4× 148 0.4× 285 1.6× 63 0.4× 263 2.4× 32 922
Paula M. Dulski United States 12 544 1.1× 156 0.4× 94 0.5× 156 1.0× 188 1.7× 14 863
Daniela Dimastrogiovanni Italy 9 370 0.7× 135 0.4× 38 0.2× 118 0.8× 51 0.5× 10 544
J. Robert Gillespie United States 19 533 1.1× 138 0.4× 26 0.2× 231 1.6× 231 2.1× 34 943
Daniel Paape United Kingdom 17 272 0.5× 98 0.3× 82 0.5× 383 2.6× 56 0.5× 22 848
Fumika Mi‐ichi Japan 17 321 0.6× 325 0.9× 55 0.3× 272 1.8× 33 0.3× 31 898
Hangjun Ke United States 12 294 0.6× 144 0.4× 46 0.3× 396 2.7× 51 0.5× 22 661
Annalisa Basso Italy 11 288 0.6× 524 1.4× 16 0.1× 189 1.3× 23 0.2× 14 882
Kylie A. Mullin Australia 11 324 0.7× 172 0.5× 69 0.4× 456 3.1× 37 0.3× 11 813
Mauro F. Azevedo Brazil 16 241 0.5× 192 0.5× 76 0.4× 596 4.0× 40 0.4× 27 880

Countries citing papers authored by Julien Lancelot

Since Specialization
Citations

This map shows the geographic impact of Julien Lancelot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Lancelot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Lancelot more than expected).

Fields of papers citing papers by Julien Lancelot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Lancelot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Lancelot. The network helps show where Julien Lancelot may publish in the future.

Co-authorship network of co-authors of Julien Lancelot

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Lancelot. A scholar is included among the top collaborators of Julien Lancelot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Lancelot. Julien Lancelot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caby, Stéphanie, Julien Lancelot, Sophie Salomé‐Desnoulez, et al.. (2021). Histone deacetylase 8 interacts with the GTPase SmRho1 in Schistosoma mansoni. PLoS neglected tropical diseases. 15(11). e0009503–e0009503. 3 indexed citations
2.
Heimburg, Tino, Julien Lancelot, Conrad V. Simoben, et al.. (2021). Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis. European Journal of Medicinal Chemistry. 225. 113745–113745. 11 indexed citations
3.
Rotili, Dante, Julien Lancelot, Martin Marek, et al.. (2019). Structure–Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Schistosoma mansoni ( Sm Sirt2). Journal of Medicinal Chemistry. 62(19). 8733–8759. 16 indexed citations
4.
Kalinin, Dmitrii V., Alokta Chakrabarti, Jelena Melesina, et al.. (2019). Structure‐Based Design, Synthesis, and Biological Evaluation of Triazole‐Based smHDAC8 Inhibitors. ChemMedChem. 15(7). 571–584. 20 indexed citations
5.
Marek, Martin, T.B. Shaik, Tino Heimburg, et al.. (2018). Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants. Journal of Medicinal Chemistry. 61(22). 10000–10016. 91 indexed citations
6.
Chakrabarti, Alokta, Julien Lancelot, T.B. Shaik, et al.. (2018). Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as SmHDAC8 Inhibitors for the Treatment of Schistosomiasis. ChemMedChem. 13(15). 1517–1529. 15 indexed citations
7.
Caby, Stéphanie, et al.. (2017). Analysis of the interactome of Schistosoma mansoni histone deacetylase 8. PLoS neglected tropical diseases. 11(11). e0006089–e0006089. 6 indexed citations
8.
Chakrabarti, Alokta, Jelena Melesina, Finn K. Hansen, et al.. (2017). Isophthalic Acid‐Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni. Archiv der Pharmazie. 350(8). 15 indexed citations
9.
Xu, Weijun, Julien Lancelot, Gérald F. Späth, et al.. (2016). Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth. International Journal for Parasitology Drugs and Drug Resistance. 7(1). 42–50. 75 indexed citations
10.
Heimburg, Tino, Alokta Chakrabarti, Julien Lancelot, et al.. (2016). Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis. Journal of Medicinal Chemistry. 59(6). 2423–2435. 93 indexed citations
11.
Lancelot, Julien, Alejandro Cabezas‐Cruz, Stéphanie Caby, et al.. (2015). Schistosome Sirtuins as Drug Targets. Future Medicinal Chemistry. 7(6). 765–782. 16 indexed citations
12.
Cabezas‐Cruz, Alejandro, James J. Valdés, Julien Lancelot, & Raymond J. Pierce. (2015). Fast evolutionary rates associated with functional loss in class I glucose transporters of Schistosoma mansoni. BMC Genomics. 16(1). 980–980. 9 indexed citations
13.
Morel, Marion, et al.. (2014). Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis. International Journal for Parasitology Drugs and Drug Resistance. 4(3). 256–266. 29 indexed citations
14.
Schiedel, Matthias, Martin Marek, Julien Lancelot, et al.. (2014). Fluorescence-Based Screening Assays for the NAD+-Dependent Histone Deacetylase smSirt2 from Schistosoma mansoni. SLAS DISCOVERY. 20(1). 112–121. 14 indexed citations
15.
Carneiro, Vitor Coutinho, Eduardo José Lopes Torres, Stéphanie Caby, et al.. (2014). Epigenetic Changes Modulate Schistosome Egg Formation and Are a Novel Target for Reducing Transmission of Schistosomiasis. PLoS Pathogens. 10(5). e1004116–e1004116. 43 indexed citations
16.
Cabezas‐Cruz, Alejandro, Julien Lancelot, Stéphanie Caby, Guilherme Oliveira, & Raymond J. Pierce. (2014). Epigenetic control of gene function in schistosomes: a source of therapeutic targets?. Frontiers in Genetics. 5. 317–317. 27 indexed citations
17.
Stolfa, Diana A., Martin Marek, Julien Lancelot, et al.. (2014). Molecular Basis for the Antiparasitic Activity of a Mercaptoacetamide Derivative That Inhibits Histone Deacetylase 8 (HDAC8) from the Human Pathogen Schistosoma mansoni. Journal of Molecular Biology. 426(20). 3442–3453. 56 indexed citations
18.
Lancelot, Julien, Stéphanie Caby, Mathieu Vanderstraete, et al.. (2013). Schistosoma mansoni Sirtuins: Characterization and Potential as Chemotherapeutic Targets. PLoS neglected tropical diseases. 7(9). e2428–e2428. 64 indexed citations
19.
Vanderstraete, Mathieu, Nadège Gouignard, Katia Cailliau, et al.. (2013). Dual Targeting of Insulin and Venus Kinase Receptors of Schistosoma mansoni for Novel Anti-schistosome Therapy. PLoS neglected tropical diseases. 7(5). e2226–e2226. 39 indexed citations
20.
Marek, Martin, Srinivasaraghavan Kannan, Alexander‐Thomas Hauser, et al.. (2013). Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni. PLoS Pathogens. 9(9). e1003645–e1003645. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026